Page last updated: 2024-08-23

epirubicin and Carcinoma, Ductal, Breast

epirubicin has been researched along with Carcinoma, Ductal, Breast in 156 studies

Research

Studies (156)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's14 (8.97)18.2507
2000's60 (38.46)29.6817
2010's78 (50.00)24.3611
2020's4 (2.56)2.80

Authors

AuthorsStudies
Broeks, A; Cimino-Mathews, A; Daletzakis, A; de Boo, L; Hooijberg, E; Horlings, HM; Kok, M; Linn, S; Loncova, Z; Lubeck, Y; Opdam, M; Rieder, D; Sanders, J; Sobral-Leite, M; Trajanoski, Z; van de Vijver, K; van der Wiel, R; van Rossum, A; van Tinteren, H; Vollebergh, M1
Fujisawa, T; Higaki, K; Ishiguro, H; Kadoya, T; Kaneko, K; Masuda, N; Matsunami, N; Mizutani, M; Morimoto, T; Morita, S; Ohno, S; Ohtani, S; Sato, N; Takahashi, M; Takano, T; Tanaka-Mizuno, S; Toi, M; Yamamoto, Y; Yanagita, Y1
Fan, Z; He, Y; Li, J; Li, Y; Ouyang, T; Wang, L; Wang, T; Xie, Y1
Antognelli, C; Crinò, L; Eliana, R; Floriani, I; Foglietta, J; Gori, S; Ludovini, V; Minenza, E; Nocentini, G; Piattoni, S; Pistola, L; Rulli, A; Sidoni, A; Talesa, VN; Tofanetti, FR; Tonato, M1
Hazama, Y; Ishida, T; Kurebayashi, J; Matsumoto, K; Matsumoto, R; Moriya, T; Murata, S; Murata, T; Nakai, Y; Nakamura, T; Nomura, T; Shimoya, K; Sugawara, S; Sugihara, M1
Banke, A; Cold, S; Dahl, JS; Ewertz, M; Fosbøl, EL; Gislason, GH; Jensen, MB; Møller, JE; Poulsen, MK; Schou, M; Videbæk, L1
Huang, L; Meng, L; Xu, Y; Zhang, W1
Jiang, Y; Peng, Q; Tang, Z; Zhou, Q1
Chen, J; Huan, Y; Li, D; Wang, J; Wang, L; Wang, T; Yao, Q; Yu, M; Zhang, J; Zhou, X1
Azama, T; Kobayashi, T; Matsuda, Y1
Chen, Q; Fan, L; Jiang, J; Qi, X; Wang, S; Yang, X; Zhang, Y1
Barinoff, J; Bauerfeind, I; Belau, A; Clemens, M; Conrad, B; Diel, IJ; Elling, D; Forstbauer, H; Harbeck, N; Huober, J; Jackisch, C; Kreienberg, R; Loibl, S; Lück, HJ; Möbus, V; Müller, V; Nekljudova, V; Noeding, S; Schmidt, M; Schneeweiss, A; Thomssen, C; Untch, M; von Minckwitz, G1
Barba, M; Del Medico, P; Di Lauro, L; Giannarelli, D; Laudadio, L; Maugeri-Saccà, M; Pizzuti, L; Sergi, D; Tomao, S; Vici, P1
Alba, E; de la Torre-Cabrera, C; Fernández, M; Fernández-Navarro, M; Jaén-Morago, A; Pascual, J; Plata-Fernández, Y; Ramirez-Tortosa, C; Sánchez-Muñoz, A; Sánchez-Rovira, P1
Blohmer, JU; Eggemann, H; Eidtmann, H; Fasching, PA; Gerber, B; Hanusch, C; Hauschild, M; Huober, J; Jackisch, C; Kittel, K; Kreienberg, R; Kunz, G; Loibl, S; Nekljudova, V; Rezai, M; Schrader, I; Solbach, C; Tesch, H; Untch, M; von Minckwitz, G1
Campanella, G; Clemente, C; D'Attoma, B; Giotta, F; Linsalata, M; Orlando, A; Riezzo, G; Russo, F2
Bauerfeind, I; Blohmer, JU; Costa, SD; Denkert, C; Eidtmann, H; Fasching, PA; Gerber, B; Hanusch, C; Hilfrich, J; Huober, J; Jackisch, C; Kümmel, S; Loibl, S; Mehta, K; Paepke, S; Rezai, M; Schneeweiss, A; Tesch, H; Untch, M; von Minckwitz, G1
Barba, G; Cicconi, L; Divona, M; Falini, B; Hasan, SK; Lo-Coco, F; Mecucci, C; Metzler, M; Ottone, T1
Champagne, C; Gaillot-Petit, N; Guilbert, P; Lamberth, F; Looten-Vieren, L; Nguyen, TD1
Bartsch, R; Dubsky, P; Fesl, C; Fitzal, F; Gampenrieder, SP; Gnant, M; Greil, R; Hartmann, BL; Hubalek, M; Jakesz, R; Lang, A; Melbinger, E; Mlineritsch, B; Muss, C; Petzer, AL; Ressler, S; Rudas, M; Singer, CF; Steger, GG; Stoeger, H; Zielinski, CC1
Colleoni, M; Iorfida, M; Montagna, E; Peccatori, F; Petralia, G; Tomasi Cont, N1
Ng, CH; Rozita, AM; Taib, NA; Tiong, V; Yip, CH1
Ameye, L; Bozovic-Spasojevic, I; de Azambuja, E; Di Leo, A; Dolci, S; Larsimont, D; Loi, S; Paesmans, M; Piccart, M1
Chan, MS; Chen, SF; Chow, LW; Felizola, SJ; Ishida, T; Nemoto, N; Ohuchi, N; Sasano, H; Tamaki, K; Wang, L1
Babu, S; Das, U; Govind Babu, K; Jacob, L; Lakshmaiah, KC; Lokanatha, D; Suresh, TM1
Li, J; Li, X; Liu, H; Liu, M; Wang, J; Xu, J; Yang, H; Zhang, Y1
Adachi, S; Endo, I; Ichikawa, Y; Ishikawa, T; Kida, K; Narui, K; Sasaki, T; Satake, T; Shimada, K; Shimizu, D; Sugae, S; Tanabe, M; Yamada, A1
Arakawa, A; Harada-Shoji, N; Himuro, T; Hino, O; Horimoto, Y; Igari, F; Mamat, O; Saito, M; Sonoue, H; Tanabe, M; Tokuda, E; Yoshida, Y1
Amarillo, I; Fisher, SI; Rashidi, A1
Fu, L; Gu, F; Guo, X; Li, H; Li, S; Li, X; Liu, F; Zhai, L; Zhang, X1
Abrial, C; Bensussan, A; Curé, H; de Boissieu, P; Garbar, C; Kwiatkowski, F; Mombelli, S; Wang-Lopez, Q1
Chavez-MacGregor, M; Gonzalez-Angulo, AM; Hortobagyi, GN; Hunt, KK; Lei, X; Mittendorf, EA; Parinyanitikul, N; Valero, V; Zhang, H1
Kagara, N; Kim, SJ; Maruyama, N; Michishita, S; Naoi, Y; Noguchi, S; Shimazu, K; Shimoda, M; Shimomura, A; Sota, Y1
Boukovinas, I; Georgoulias, V; Kakolyris, S; Kentepozidis, N; Malamos, N; Mavroudis, D; Papakotoulas, P; Saloustros, E; Ziras, N1
Bachelot, T; Boher, JM; Delva, R; Dohollou, N; Eymard, JC; Fabbro, M; Ferrero, JM; Gonçalves, A; Leduc, B; Lemonnier, J; Lerebours, F; Linassier, C; Lotz, JP; Martin, AL; Mouret-Reynier, MA; Pierga, JY; Roché, H; Viens, P1
Darb-Esfahani, S; Denkert, C; Eidtmann, H; Fasching, PA; Furlanetto, J; Hartmann, A; Huober, J; Jackisch, C; Klimowicz, A; Lederer, B; Loibl, S; Mehta, K; Pfitzner, B; Tiemann, K; Untch, M; von Minckwitz, G1
Kanada, Y; Kobayashi, H; Maruyama, T; Matsuzaki, H; Miyazaki, A; Natsume, T; Note, H; Sato, Y; Sawada, H; Senba, Y; Suzuki, K; Tanaka, H; Yoshioka, T1
Che, S; Li, J; Ou, Y; Wang, M; Wu, B; Zhao, X; Zhou, C1
Chen, K; Chen, Y; Gong, C; Nie, Y; Qu, S; Song, E; Su, F; Xiao, X1
Du, J; Fan, L; Jiang, J; Liang, Q; Liu, J; Ming, J; Zhang, Y; Zhong, L1
Capelan, M; Lote, H; Mohammed, K; Papadimitraki, E; Redana, S; Ring, A; Sharp, A1
Kang, Y; Li, J; Ma, Y; Ren, W; Zang, L; Zhang, S1
Alunni-Fabbroni, M; Andergassen, U; Camara, O; de Gregorio, N; Decker, T; Fasching, PA; Fehm, TN; Friedl, TWP; Heinrich, G; Jaeger, B; Janni, W; Mahner, S; Ober, A; Pantel, K; Rack, BK; Schneeweiss, A; Schochter, F; Schramm, A; Trapp, E1
Coleman, RE; El-Helw, LM; Hatton, MQ; Purohit, OP; Zekri, JM1
Ardavanis, A; Basioukas, S; Orphanos, G; Rigatos, G; Skafida, S1
Bowman, A; Coleman, RE; Dunn, JA; Earl, HM; Fernando, IN; Hiller, L; Howard, HC; Poole, CJ; Ritchie, DM; Wardley, AM1
de la Torre-Cabrera, C; Dueñas, B; Dueñas-García, R; Fernández-Navarro, M; García-Tapiador, AM; Jaén-Morago, A; Martín-Salvago, MD; Martínez-Ortega, E; Morales, F; Ortega-Granados, AL; Ramírez-Torosa, C; Rueda, AI; Sánchez-Muñoz, A; Sánchez-Rovira, P1
Agarwal, R; Ashley, S; Chua, S; Johnston, S; Jones, RL; O'Brien, M; Smith, IE; Walsh, G1
Duarte, M; García-Sancho, L; Gil-López, JM; Trébol, J1
Jaen, P; Vano-Galvan, S1
Boidot, R; Coudert, B; Fumoleau, P; Lizard-Nacol, S; Soubeyrand, MS; Vegran, F1
Fu, JF; Hong, ZW; Wang, B1
Brites, MM; Figueiredo, A; Frutuoso, C; Saleiro, S; Santiago, F1
Fukuda, S; Hiraki, S; Kawaoka, T; Matsui, H; Nagashima, A1
Hasegawa, N; Iimura, Y; Kaneko, H; Kawabata, M; Konishi, K; Shoji, Y1
Li, T; Liu, YH; Qin, XQ; Wang, YH; Ye, JM; Yin, HF; Zhang, H1
Accorsi, P; Candeloro, G; Necozione, S; Rea, S; Recchia, CO; Recchia, F; Tombolini, V1
Domoto, K; Fujibayashi, M; Hirano, A; Kamimura, M; Kim, N; Kimura, K; Kinoshita, J; Ogawa, K; Shimizu, T; Watanabe, O1
Aoki, T; Longui, CA; Melo, MB; Oliveira, AL; Rocha, MN; Rodrigues, FF; Santos, RE1
Dufour, P; Fricker, JP; Ghnassia, JP; Petit, T; Rodier, JF; Velten, M; Wilt, M1
Allmaier, G; Bachleitner-Hofmann, T; Bartsch, R; Baumann, S; Bergmann, M; Burghuber, C; Gnant, M; Graf, A; Greil, R; Marchetti-Deschmann, M; Michlmayr, A; Oehler, R; Pluschnig, U; Rech-Weichselbraun, I; Steger, G1
Breugelmans, M; De Greve, J; Foulon, W; Keymolen, K; Laubach, M; Leyder, M1
Hirakawa, K; Ishikawa, T; Kashiwagi, S; Kato, Y; Kawajiri, H; Nakata, B; Noda, S; Onoda, N; Takashima, T1
Balslev, E; Bernsdorf, M; Ejlertsen, B; Ingvar, C; Jakobsen, EH; Jörgensen, L; Kimper-Karl, ML; Kroman, N; Saetersdal, A; Tuxen, MK1
Arriagada, R; Bourgier, C; Dunant, A; Heymann, S; Marsiglia, H; Mathieu, MC; Pessoa, EL; Spielmann, M; Uzan, C1
Kajiura, Y; Yagata, H; Yamauchi, H1
Bando, H; Iwata, H; Kashiwaba, M; Mizuno, T; Murakami, S; Nakayama, T; Ohashi, Y; Sawaki, M; Taira, N; Tokudome, N; Uemura, Y; Yamamoto, Y1
Baak, JP; Gilje, B; Janssen, EA; Nordgård, O; Smaaland, R; Søiland, H; Tjensvoll, K1
Arnold, I; Shipman, KE1
Clemens, MR; Darb-Esfahani, S; Denkert, C; Diebold, K; Dietrich, K; Eidtmann, H; Hanusch, C; Henschen, S; Hoffmann, G; Holms, F; Huober, J; Just, M; Loibl, S; Schrader, I; Solbach, C; Tesch, H; Tiemann, K; Untch, M; von Minckwitz, G1
Cortesi, E; Frati, L; Gandini, O; Gazzaniga, P; Gradilone, A; Naso, G; Nicolazzo, C; Palazzo, A; Petracca, A; Raimondi, C1
Brodowicz, T; Csörgo, E; Kahán, Z; Kaizer, L; Lázár, G; Nikolényi, A; Ormándi, K; Sükösd, F; Thurzó, L; Uhercsák, G; Vörös, A1
Beck, T; Camara, O; du Bois, A; Fasching, PA; Fett, W; Harbeck, N; Hasmüller, S; Höss, C; Kahlert, S; Konecny, GE; Kreienberg, R; Kühn, T; Lebeau, A; Loibl, S; Mehta, KM; Müller, V; Stickeler, E; Untch, M; von Minckwitz, G1
Akazawa, K; Ishihara, H; Kim, SJ; Matsushima, T; Nakayama, S; Noguchi, S; Shibayama, M; Shimazu, K; Tamaki, Y; Torikoshi, Y; Tsukamoto, F1
Chen, SF; Gong, C; Luo, M; Su, FX; Yao, HR; Zeng, YJ1
Farkas, R; Horváth, OP; Kálmán, E; Kovács, G; Kövér, E; Pavlovics, G; Szalai, G; Tizedes, G; Zapf, I1
Chen, CM; Chen, S; Shao, ZM; Yang, WT; Yu, KD1
Cui, SD; Li, LF; Li, WL; Liu, H; Liu, ZZ; Lu, ZD; Yang, H; Zhang, HW1
Ahlgren, J; Asola, R; Auvinen, P; Bono, P; Helle, L; Huovinen, R; Joensuu, H; Jukkola-Vuorinen, A; Kataja, V; Kellokumpu-Lehtinen, PL; Kokko, R; Leinonen, M; Lindman, H; Nilsson, G; Nyandoto, P; Paija, O; Pajunen, M; Poikonen, P; Tanner, M; Villman, K1
Breidenbach, M; Duda, V; Eichler, C; Gossmann, A; Harbeck, N; Hoopmann, M; Kates, RE; Ohlinger, R; Thomas, A; Warm, M1
Chen, S; Fu, R; Gu, H; Li, Q; Wang, Y; Wu, H; Yuan, K; Zhang, K; Zhang, L1
Fu, J; Leng, H; Liang, L; Liu, YL; Xing, W; Zhang, HW1
Guli, KZ; Guo, L; Hu, X; Li, X; Li, Y; Liu, W; Ma, Y; Wen, SJ; Yang, SE; Zhao, B1
Chen, CM; Chen, S; Shao, ZM; Yu, KD; Zhou, RJ1
Crespo-Torres, S; Gonzalez-Perez, LM; Infante-Cossio, P; Sanchez-Gallego, F1
Bleuse, JP; Chapelle, A; Jacot, W; Lamy, PJ; Pouderoux, S; Romieu, G; Thezenas, S1
Chen, J; Chen, YJ; Li, HJ; Lv, Q; Tian, CX; Wang, XD; Yang, Q1
Beckmann, MW; Dimmler, A; Fasching, PA; Haeberle, L; Hartmann, A; Koscheck, T; Lux, MP; Rauh, C; Renner, SP; Schrauder, MG; Schulz-Wendtland, R; Wachter, DL1
Fan, Y; Li, Q; Ma, F; Wang, JY; Wang, WM; Xu, BH; Yuan, P; Zhang, P1
Cao, X; Xue, J; Zhao, B1
Blot, E; Bonneterre, J; Desauw, C; Fournier, C; Hornez, L; Kramar, A; Peyrat, JP; Révillion, F1
Fersching, DM; Holdenrieder, S; Lehner, J; Nagel, D; Stötzer, OJ1
Alba-Conejo, E; de la Torre-Cabrera, C; Fernández, M; Fernández-Navarro, M; Jaén-Morago, A; Llácer, C; Lomas-Garrido, M; Navarro-Perez, V; Plata-Fernández, YM; Ramirez-Tortosa, C; Sánchez-Muñoz, A; Sánchez-Rovira, P1
Carrara, HH; Silva, LM; Takahashi, CS1
Ahern, R; Archer, C; Dowsett, M; Krajewska, M; Krajewski, S; Naito, M; Parton, M; Reed, J; Smith, I1
Inaji, H; Kasugai, T; Koizumi, M; Komoike, Y; Koyama, H; Motomura, K; Nose, T; Sawai, Y1
Abali, H; Celik, I1
Brinkbäumer, K; Hahn, K; Kessler, M; Linke, R; Sommer, H; Tiling, R; Untch, M1
Buch, RS; Reichert, TE; Schmidt, M1
Buksmaui, S; Hausmaninger, H; Heinrich, B; Höffken, K; Krejcy, K; Miller, MA; Morack, G; Possinger, K; Wallwiener, D1
He, PQ; Li, YF; Liu, GY; Shen, ZZ; Sheng, Y; Shi, JY; Su, FX; Yang, MT; Zou, Q1
Allred, DC; Arpino, G; Ciocca, DR; Daguerre, P; Elledge, R; Gago, F; Leuzzi, M; Mohsin, SK; Vargas-Roig, L; Weiss, H1
Annane, K; Bergerat, JP; Dufour, P; Liegeois, P; Mathelin, C1
Hitzl, W; Peintinger, F; Prokop, E; Reitsamer, R1
Pan, CE; Wu, WJ; Zeng, J2
Cold, S; Düring, M; Ewertz, M; Knoop, A; Møller, S1
Bolton-Maggs, P; Flavin, A1
Chen, L; Jiang, WZ; Lu, YF; Pan, CE; Wu, WJ; Zeng, J1
Bonneterre, J; Campone, M; Fargeot, P; Kerbrat, P; Luporsi, E; Monnier, A; Montcuquet, P; Namer, M; Roché, H; Romestaing, P1
Bafaloukos, D; Bourli, A; Christodoulou, C; Dafni, U; Fillipidis, T; Fountzilas, G; Gogas, H; Kafiri, G; Karagianni, E; Kyriakou, V; Malamou-Mitsi, V; Markaki, S; Papadopoulos, S; Papakostas, P; Papaspyrou, I; Pavlakis, K; Scopa, C; Sotiropoulou, M; Toliou, T; Tzaida, O; Vlachodimitropoulos, D1
Boidot, R; Bonnetain, F; Lizard-Nacol, S; Oudin, C; Riedinger, JM; Végran, F1
Angellier, E; Berdah, JF; Buyse, M; Fabbro, M; Greget, S; Herait, P; Jehl, V; Laplaige, P; Piedbois, P; Priou, F; Serin, D; Teissier, E; Valenza, B1
Blanc-Fournier, C; Chasle, J; Guedin, P; Lacroix, J1
Karakuzu, A; Koc, M; Ozdemir, S1
Hata, Y; Taguchi, K; Takahashi, H; Takahashi, M; Tamura, M; Todo, S; Watanabe, K1
Calpena, R; Cansado Martínez, P; Lacueva Gómez, FJ; Martínez Banaclocha, N; Merck, B; Pérez Ramos, M1
Andre, F; Broglio, K; Buzdar, AU; Cristofanilli, M; Esteva, FJ; Fritsche, H; Hall, A; Hortobagyi, GN; Mazouni, C; Pusztai, L1
Suzuki, M1
Ando, M; Matsuyama, Y; Ooi, Y; Rai, Y; Sagara, Y; Takahama, T; Tamada, S; Tsuchimochi, S1
Ames, FC; Babiera, GV; Feig, BW; Francis, A; Gilcrease, MZ; Hunt, KK; Kuerer, HM; Meric-Bernstam, F; Ross, MI; Shen, J1
Jiang, DQ; Li, S; Long, F; Xu, H; Zhang, B; Zhang, Q; Zhao, L1
Galid, A; Gnant, M; Greil, R; Haid, A; Jakesz, R; Klug, E; Kubista, E; Kwasny, W; Lang, A; Luschin-Ebengreuth, G; Menzel, C; Mlineritsch, B; Pöstlberger, S; Rudas, M; Samonigg, H; Singer, CF; Steger, GG; Tausch, C; Wenzel, C1
Adjadj, DJ; Aubard, Y; Benyoub, A; Bonnier, P; Clavère, P; Genet, D; Juin, P; Labourey, JL; Lebrun-Ly, V; Lejeune, C; Martin, J; Piana, L; Tubiana-Mathieu, N; Venat-Bouvet, L1
Akiyama, F; Horii, R; Ito, Y; Iwase, T; Matsuura, M; Miki, Y1
Brock, CS; Eccles, S; Francis, N; Lim, A; McLean, SR; Nathan, M; Palmieri, C; Shousha, S1
Benítez-Bribiesca, L; Bravo, JL; Del Castillo, ER; Gallegos-Hernández, F; Ostrosky-Wegman, P; Peñarroja-Flores, R; Sánchez-Suárez, P; Toledo-García, J1
Jin, WR; Li, LF; Liu, ZB; Shao, ZM; Shen, ZZ; Xu, XJ; Zhao, Y1
Hamaoka, T; Hayashi, N; Kawasaki, T; Kikuchi, M; Nakamura, S; Suzuki, K; Tsugawa, K; Tsunoda-Shimizu, H; Yagata, H1
Hao, XM; Hui, R; Zhang, J; Zhang, M1
Arima, N; Iwase, H; Kai, K; Miyayama, H; Nishimura, R; Yamamoto, Y1
Adrover, E; Alba, E; Almenar, S; Alvarez, I; Alvarez, JV; Antón, A; Aranda, E; Baena, JM; Calvo, L; Crespo, C; de Alava, E; García Puche, JL; Gonzalez, S; González-Palacios, JF; Gracia Marco, JM; Guitián, MD; Lluch, A; López García-Asenjo, JA; López-Vega, JM; Martín, M; Mayordomo, JI; Mel, JR; Modolell, A; Munárriz, B; Palacios, J; Pelegrí, A; Plazaola, A; Ramos, M; Rodríguez, CA; Rodríguez-Lescure, A; Ruiz, A; Ruiz-Borrego, M; Sánchez-Rovira, P; Seguí, MA; Vera, F1
Matsuno, S; Migita, T; Saito, Y; Shibata, C; Shiiba, K1
Bastert, G; Huober, J; Junkermann, H; Kaufmann, M; Leppien, G; Otto, HF; Schmid, H; Sinn, HP1
Berger, C; Body, G; Bougnoux, P; Calais, G; Chapet, S; Descamps, P; Lansac, J; Le Floch, O; Reynaud-Bougnoux, A1
Ogawa, Y; Ogoshi, S; Ohmori, Y; Okazaki, Y; Tanaka, Y; Toki, T1
Junkermann, H; Schmid, H; Sinn, HP; Wallwiener, D1
Camargo, EE; Coudry, R; Joaquim, AI; Ramos, CD; Sagarra, AJ; Sagarra, RA1
Rieger, N; Stahl, J; Wattchow, D1
Basser, RL; Beaty, AE; Busmanis, IA1
Fujitake, S; Kataoka, S; Maeda, Y; Nozaki, H; Shimizu, M; Tohyama, M1
Arnoud, L; Belichard, C; Coudert, B; Darut-Jouve, A; Guerrin, J; Jolimoy, G1
Chen, Z; Li, G; Liu, F1
Emi, Y; Kai, S; Kano, T; Nishijima, N; Rai, Y1
Hada, M; Hagiwara, J; Kamiya, K; Koshizuka, K; Muto, S; Nakagomi, H; Tada, Y; Takano, K1
Hirata, K; Ohmura, T; Ohshima, H; Okazaki, A; Okazaki, M; Watanabe, Y; Yamamoto, M; Yamashiro, K1
Avril, N; Dose, J; Graeff, H; Jänicke, F; Kuhn, W; Nährig, J; Römer, W; Sattler, D; Schelling, M; Schwaiger, M; Werner, M1
Dai, A; Feng, J; Zheng, X1
Asselain, B; Beuzeboc, P; Diéras, V; Dorval, T; Extra, JM; Jouve, M; Laurence, V; Mouret, E; Palangié, T; Pierga, JY; Pouillart, P; Scholl, S; Vincent-Salomon, A1
Hlawatsch, A; Hoffmann, G; Kuner, RP; Teifke, A; Thelen, M; Zamboglou, N1
Cho, KH; Choi, SM; Kim, BC; Kim, MK; Lee, SH; Yang, YS1
Kawahara, H; Sakurai, T; Tatematsu, H; Yamamoto, T; Yamataka, K1
Hara, Y; Hikosaka, Y; Iwase, H; Kobayashi, S; Toyama, T; Yamashita, H1
Haegele, P; Lehmann, S; Moyses, B; Petit, T; Rodier, JF; Schraub, S; Velten, M1
Gnant, MF; Jakesz, R; Locker, GJ; Rudas, M; Schmidinger, M; Steger, GG; Taucher, S; Wenzel, C1

Reviews

2 review(s) available for epirubicin and Carcinoma, Ductal, Breast

ArticleYear
Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy.
    Breast cancer (Tokyo, Japan), 2011, Volume: 18, Issue:3

    Topics: Adult; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Mastectomy, Segmental; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Platinum; Receptors, Estrogen; Taxoids

2011
Breast-conserving treatment after neoadjuvant chemotherapy in large breast cancer.
    Breast cancer (Tokyo, Japan), 2002, Volume: 9, Issue:1

    Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Epirubicin; Female; Humans; Mastectomy, Segmental; Neoadjuvant Therapy; Neoplasm Recurrence, Local

2002

Trials

43 trial(s) available for epirubicin and Carcinoma, Ductal, Breast

ArticleYear
Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy.
    European journal of cancer (Oxford, England : 1990), 2020, Volume: 127

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; BRCA1 Protein; BRCA2 Protein; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphocytes, Tumor-Infiltrating; Mutation; Neoplasm Recurrence, Local; Neoplasm Staging; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Survival Rate; Thiotepa; Triple Negative Breast Neoplasms

2020
A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer.
    Breast cancer research and treatment, 2020, Volume: 180, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Young Adult

2020
Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: efficacy and safety in a prospective, randomized, phase II study.
    BMC cancer, 2013, May-21, Volume: 13

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Docetaxel; Endostatins; Epirubicin; Female; Follow-Up Studies; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Prospective Studies; Quality of Life; Taxoids; Young Adult

2013
German adjuvant intergroup node-positive study: a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Oct-01, Volume: 31, Issue:28

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Deoxycytidine; Diphosphonates; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Germany; Humans; Ibandronic Acid; Middle Aged; Neoplasm Grading; Neoplasm Staging; Paclitaxel; Prognosis; Survival Rate; Young Adult

2013
Tumor histological subtyping determined by hormone receptors and HER2 status defines different pathological complete response and outcome to dose-dense neoadjuvant chemotherapy in breast cancer patients.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2014, Volume: 16, Issue:6

    Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Deoxycytidine; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Immunoenzyme Techniques; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Prognosis; Prospective Studies; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Remission Induction; Survival Rate; Trastuzumab

2014
Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:12

    Topics: Adult; Aged; Anthracyclines; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Everolimus; Female; Humans; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Paclitaxel; Sirolimus; Treatment Outcome; Triple Negative Breast Neoplasms; Tumor Burden; Ultrasonography; Young Adult

2013
Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40--GeparQuattro).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2014, Volume: 25, Issue:1

    Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Deoxycytidine; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Neoadjuvant Therapy; Proportional Hazards Models; Taxoids; Trastuzumab; Treatment Outcome

2014
Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2014, Volume: 25, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Deoxycytidine; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Neoadjuvant Therapy; Prospective Studies; Taxoids; Treatment Outcome; Young Adult

2014
Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Immunoenzyme Techniques; Middle Aged; Neoplasm Grading; Prognosis; Receptor, ErbB-2; Survival Rate; Taxoids; Time Factors; Trastuzumab; Young Adult

2015
UNICANCER-PEGASE 07 study: a randomized phase III trial evaluating postoperative docetaxel-5FU regimen after neoadjuvant dose-intense chemotherapy for treatment of inflammatory breast cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:8

    Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Axilla; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Inflammatory Breast Neoplasms; Lymph Node Excision; Mastectomy; Middle Aged; Neoadjuvant Therapy; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Taxoids

2015
Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.
    Clinical breast cancer, 2017, Volume: 17, Issue:4

    Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Neoplasm Invasiveness; Neoplastic Cells, Circulating; Prevalence; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Taxoids; Young Adult

2017
tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluation.
    British journal of cancer, 2008, Aug-19, Volume: 99, Issue:4

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Deoxycytidine; Disease-Free Survival; Epirubicin; Female; Gemcitabine; Heart; Heart Function Tests; Humans; Liver; Liver Function Tests; Lung; Paclitaxel; Prospective Studies; Respiratory Function Tests; Survival Rate

2008
Tumour molecular subtyping according to hormone receptors and HER2 status defines different pathological complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2008, Volume: 10, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Disease Progression; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; Middle Aged; Molecular Diagnostic Techniques; Neoadjuvant Therapy; Prognosis; Receptors, Cytoplasmic and Nuclear; Remission Induction

2008
A randomised pilot Phase II study of doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC) given 2 weekly with pegfilgrastim (accelerated) vs 3 weekly (standard) for women with early breast cancer.
    British journal of cancer, 2009, Jan-27, Volume: 100, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Epirubicin; Feasibility Studies; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Heart; Humans; Maximum Tolerated Dose; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neutropenia; Patient Selection; Pilot Projects; Polyethylene Glycols; Prognosis; Recombinant Proteins; Survival Rate; Treatment Outcome

2009
Variations in gene expression and response to neoadjuvant chemotherapy in breast carcinoma.
    Cancer investigation, 2009, Volume: 27, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Neoadjuvant Therapy; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Taxoids; Treatment Outcome

2009
Prolonged disease control after myeloablative chemotherapy, autologous transplantation and immunotherapy in high-risk early breast cancer.
    Anticancer research, 2010, Volume: 30, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; CD4-CD8 Ratio; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Hematopoietic Stem Cell Transplantation; Humans; Interleukin-2; Killer Cells, Natural; Methotrexate; Middle Aged; Neoplasm Staging; Prospective Studies; Treatment Outcome; Tretinoin

2010
Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value.
    British journal of cancer, 2010, Oct-12, Volume: 103, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Pharmacological; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Complement System Proteins; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Middle Aged; Neoadjuvant Therapy; Plasma; Predictive Value of Tests; Taxoids; Validation Studies as Topic

2010
Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial.
    Breast cancer research and treatment, 2011, Volume: 126, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Double-Blind Method; Epirubicin; Female; Fever; Gefitinib; Humans; Leukopenia; Middle Aged; Neoadjuvant Therapy; Neutropenia; Quinazolines; Receptors, Estrogen; Research Design; Treatment Outcome; Tumor Burden

2011
Evaluation of trastuzumab without chemotherapy as a post-operative adjuvant therapy in HER2-positive elderly breast cancer patients: randomized controlled trial [RESPECT (N-SAS BC07)].
    Japanese journal of clinical oncology, 2011, Volume: 41, Issue:5

    Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cost-Benefit Analysis; Cyclophosphamide; Disease-Free Survival; Docetaxel; Doxorubicin; Epirubicin; Female; Fluorouracil; Health Status; Humans; Kaplan-Meier Estimate; Methotrexate; Paclitaxel; Prospective Studies; Quality of Life; Receptor, ErbB-2; Taxoids; Trastuzumab; Treatment Outcome

2011
Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients.
    Breast cancer research and treatment, 2011, Volume: 128, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cisplatin; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Methotrexate; Middle Aged; Mitotic Index; Neoplasm Micrometastasis; Prognosis; Tamoxifen; Treatment Outcome

2011
Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer: results from the TECHNO trial of the AGO and GBG study groups.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Sep-01, Volume: 29, Issue:25

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Epirubicin; Female; Follow-Up Studies; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Paclitaxel; Prospective Studies; Receptor, ErbB-2; Remission Induction; Survival Rate; Trastuzumab; Treatment Outcome; Young Adult

2011
Recurrence risk score based on the specific activity of CDK1 and CDK2 predicts response to neoadjuvant paclitaxel followed by 5-fluorouracil, epirubicin and cyclophosphamide in breast cancers.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; CDC2 Protein Kinase; Cyclin-Dependent Kinase 2; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Ki-67 Antigen; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Paclitaxel; Receptors, Steroid; Risk Factors; Treatment Outcome

2012
Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Jan-01, Volume: 30, Issue:1

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Deoxycytidine; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Finland; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy; Middle Aged; Neoplasm Grading; Neoplasm Staging; Prospective Studies; Survival Analysis; Taxoids; Treatment Outcome

2012
A clinical study on regional lymphatic chemotherapy using an activated carbon nanoparticle-epirubicin in patients with breast cancer.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2012, Volume: 33, Issue:6

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Apoptosis; Breast Neoplasms; Carcinoma, Ductal, Breast; Charcoal; Epirubicin; Female; Humans; Injections, Intralymphatic; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Nanoparticles; Neoplasm Staging; Prognosis

2012
[Docetaxel plus carboplatin versus EC-T as adjuvant chemotherapy for triple-negative breast cancer: safety data from a phase III randomized open-label trial].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2012, Volume: 34, Issue:6

    Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Female; Humans; Leukopenia; Middle Aged; Neoplasm Staging; Neutropenia; Premenopause; Radiotherapy, Adjuvant; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Taxoids; Vomiting

2012
The role of immunohistochemistry in breast cancer patients treated with neoadjuvant chemotherapy: an old tool with an enduring prognostic value.
    Clinical breast cancer, 2013, Volume: 13, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Deoxycytidine; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Prognosis; Prospective Studies; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Remission Induction; Retrospective Studies; Survival Rate; Young Adult

2013
The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study.
    BMC cancer, 2013, Feb-04, Volume: 13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cholera Toxin; Cyclophosphamide; Diarrhea; Enzyme-Linked Immunosorbent Assay; Epidermal Growth Factor; Epirubicin; Female; Fluorouracil; Ghrelin; Glucagon-Like Peptide 2; Haptoglobins; Humans; Intestinal Absorption; Intestinal Mucosa; Italy; Lactulose; Mannitol; Middle Aged; Peptides; Permeability; Prospective Studies; Protein Precursors; Stomatitis; Time Factors; Treatment Outcome

2013
Gemcitabine combined with epirubicin in the treatment of patients with locally advanced or metastatic breast cancer: a phase II study.
    American journal of clinical oncology, 2004, Volume: 27, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Deoxycytidine; Epirubicin; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Metastasis; Survival Analysis

2004
[Neoadjuvant chemotherapy with docetaxel plus epirubicin for locally advanced breast cancer: a multi-center phase II study].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2005, Volume: 27, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Drug Administration Schedule; Epirubicin; Female; Humans; Male; Middle Aged; Neutropenia; Paclitaxel; Remission Induction

2005
Pathological complete response rates comparing 3 versus 6 cycles of epidoxorubicin and docetaxel in the neoadjuvant setting of patients with stage II and III breast cancer.
    Anti-cancer drugs, 2005, Volume: 16, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Glucuronates; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Prospective Studies; Receptor, ErbB-2; Remission Induction; Taxoids; Treatment Outcome

2005
[Effect of preoperative lymphatic chemotherapy on Bcl-2 and Bax expression in axillary metastasis of breast cancer].
    Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA, 2005, Volume: 25, Issue:8

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Apoptosis; Axilla; bcl-2-Associated X Protein; Breast Neoplasms; Carcinoma, Ductal, Breast; Epirubicin; Female; Humans; Injections, Intralymphatic; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Preoperative Care; Proto-Oncogene Proteins c-bcl-2

2005
Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG).
    British journal of cancer, 2005, Sep-19, Volume: 93, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Prognosis; Stereoisomerism; Survival Rate; Time Factors

2005
[Impact of preoperative lymphatic chemotherapy on relapse and metastasis of breast cancer and its mechanism].
    Ai zheng = Aizheng = Chinese journal of cancer, 2005, Volume: 24, Issue:12

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Apoptosis; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Epirubicin; Fas Ligand Protein; fas Receptor; Female; Humans; Injections, Intralymphatic; Lymph Nodes; Lymphatic Metastasis; Mastectomy, Modified Radical; Middle Aged; Neoplasm Recurrence, Local; Preoperative Care; Single-Blind Method

2005
Improved disease-free survival with epirubicin-based chemoendocrine adjuvant therapy compared with tamoxifen alone in one to three node-positive, estrogen-receptor-positive, postmenopausal breast cancer patients: results of French Adjuvant Study Group 02
    Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Humans; Lymph Nodes; Middle Aged; Neoplasms, Second Primary; Postmenopause; Receptors, Estrogen; Retrospective Studies; Survival Rate; Tamoxifen

2006
Evaluation of the prognostic and predictive value of p53 and Bcl-2 in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Gene Expression; Humans; Methotrexate; Middle Aged; Molecular Diagnostic Techniques; Paclitaxel; Predictive Value of Tests; Prognosis; Proto-Oncogene Proteins c-bcl-2; Survival Analysis; Tumor Suppressor Protein p53

2006
Dose-dense adjuvant chemotherapy in node-positive breast cancer: docetaxel followed by epirubicin/cyclophosphamide (T/EC), or the reverse sequence (EC/T), every 2 weeks, versus docetaxel, epirubicin and cyclophosphamide (TEC) every 3 weeks. AERO B03 rando
    Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Feasibility Studies; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Survival Rate; Taxoids; Treatment Outcome

2007
Kinetics of serum HER-2/neu changes in patients with HER-2-positive primary breast cancer after initiation of primary chemotherapy.
    Cancer, 2007, Feb-01, Volume: 109, Issue:3

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Kinetics; Middle Aged; Neoadjuvant Therapy; Prognosis; Prospective Studies; Receptor, ErbB-2; Trastuzumab

2007
[Efficacy of activated charcoal-epirubicin suspension for treatment of breast cancer with axillary metastasis].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2006, Volume: 26, Issue:12

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Charcoal; Epirubicin; Female; Humans; Injections, Intralymphatic; Lymph Nodes; Lymphatic Metastasis; Middle Aged

2006
Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer: results of ABCSG-14.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, May-20, Volume: 25, Issue:15

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Docetaxel; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prospective Studies; Taxoids

2007
[Comparison of tolerance and toxicity of CEF-100 regimen versus CEF-60 regimen as adjuvant therapy for breast cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2007, Volume: 29, Issue:11

    Topics: Adult; Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Leukopenia; Middle Aged; Neutropenia; Vomiting

2007
Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
    Journal of the National Cancer Institute, 2008, Jun-04, Volume: 100, Issue:11

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Infusions, Intravenous; Kaplan-Meier Estimate; Middle Aged; Neoplasm Staging; Paclitaxel; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Treatment Outcome

2008
[Influence of preoperative on gastric cancer tissues and cells].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 1997, Volume: 35, Issue:5

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Preoperative Care; Stomach Neoplasms

1997
Combined analysis of two phase II trials in patients with primary and advanced breast cancer with epidoxorubicin and docetaxel+granulocyte colony stimulating factor.
    Anti-cancer drugs, 2002, Volume: 13, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Docetaxel; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Menopause; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Palliative Care; Prospective Studies; Survival Rate; Taxoids

2002

Other Studies

111 other study(ies) available for epirubicin and Carcinoma, Ductal, Breast

ArticleYear
Computed tomography reconstruction for evaluating response in axillary lymph nodes of breast cancer after neoadjuvant chemotherapy.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2021, Volume: 23, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multidetector Computed Tomography; Neoadjuvant Therapy; Neoplasm, Residual; Paclitaxel; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome

2021
Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy.
    BMC cancer, 2017, Jul-26, Volume: 17, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Gene Frequency; Genetic Association Studies; Genotype; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Kaplan-Meier Estimate; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prospective Studies

2017
[A Case Report of Surgery and Chemotherapy for a Patient with Rapidly Progressing Breast Cancer during Pregnancy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Disease Progression; Epirubicin; Female; Humans; Mastectomy, Radical; Paclitaxel; Pregnancy; Pregnancy Complications, Neoplastic

2018
Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab.
    JACC. Heart failure, 2019, Volume: 7, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cardiotoxicity; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Denmark; Docetaxel; Epirubicin; Female; Heart Failure; Humans; Incidence; Longitudinal Studies; Mastectomy, Segmental; Middle Aged; Receptor, ErbB-2; Retrospective Studies; Risk; Stroke Volume; Trastuzumab

2019
Incidence of interstitial pneumonitis in breast cancer patients treated with pegylated liposomal doxorubicin.
    Cancer chemotherapy and pharmacology, 2020, Volume: 85, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; China; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Humans; Incidence; Lung Diseases, Interstitial; Middle Aged; Neoplasm Invasiveness; Polyethylene Glycols; Prognosis; Retrospective Studies

2020
[Velocity vector imaging assessment of early epirubicin-induced myocardial damage].
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2013, Volume: 38, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Flow Velocity; Breast Neoplasms; Carcinoma, Ductal, Breast; Cardiac Volume; Case-Control Studies; Echocardiography; Elasticity Imaging Techniques; Epirubicin; Female; Humans; Middle Aged; Ventricular Dysfunction, Left

2013
[A case of a patient with breast cancer, diagnosed from sternal metastasis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Bridged-Ring Compounds; Carcinoma, Ductal, Breast; Chemoradiotherapy; Cyclophosphamide; Epirubicin; Female; Humans; Mastectomy, Segmental; Neoplasm Staging; Sternum; Taxoids

2013
Shrink pattern of breast cancer after neoadjuvant chemotherapy and its correlation with clinical pathological factors.
    World journal of surgical oncology, 2013, Jul-24, Volume: 11, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Epirubicin; Female; Follow-Up Studies; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Paclitaxel; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone

2013
Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer.
    Breast cancer research and treatment, 2013, Volume: 141, Issue:1

    Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Carcinoma, Papillary; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Docetaxel; Epirubicin; Estrogen Receptor Modulators; Estrogens; Fluorouracil; Gonadotropin-Releasing Hormone; Goserelin; Humans; Kaplan-Meier Estimate; Letrozole; Male; Mastectomy, Modified Radical; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Progesterone; Radiotherapy, Adjuvant; Tamoxifen; Taxoids; Triazoles

2013
Gut peptide profile and chemotherapy-associated dyspepsia syndrome in patients with breast cancer undergoing FEC60 chemotherapy.
    Anticancer research, 2013, Volume: 33, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Dyspepsia; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Gastrins; Gastrointestinal Motility; Gastrointestinal Tract; Ghrelin; Humans; Leptin; Middle Aged; Motilin; Neoplasm Staging; Pepsinogen A; Pepsinogen C; Peptide Fragments; Prognosis; Prospective Studies; Syndrome

2013
Clustering of genomic breakpoints at the MLL locus in therapy-related acute leukemia with t(4;11)(q21;q23).
    Genes, chromosomes & cancer, 2014, Volume: 53, Issue:3

    Topics: Antibiotics, Antineoplastic; Base Sequence; Breast Neoplasms; Carcinoma, Ductal, Breast; Chromosome Breakpoints; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 4; Epirubicin; Female; Genetic Loci; Humans; Idarubicin; Leukemia, Biphenotypic, Acute; Leukemia, Promyelocytic, Acute; Middle Aged; Molecular Sequence Data; Multigene Family; Topoisomerase Inhibitors; Translocation, Genetic

2014
[Potential indications for helical tomotherapy in breast cancers].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2014, Volume: 18, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Combined Modality Therapy; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Funnel Chest; Hodgkin Disease; Humans; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Obesity; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Taxoids

2014
Whole-body magnetic resonance imaging, metastatic breast cancer and pregnancy: a case report.
    Breast (Edinburgh, Scotland), 2014, Volume: 23, Issue:3

    Topics: Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Epirubicin; Female; Humans; Labor, Induced; Magnetic Resonance Imaging; Mastectomy, Modified Radical; Neoplasm Staging; Pregnancy; Pregnancy Complications, Neoplastic; Radiotherapy; Tamoxifen; Treatment Outcome; Whole Body Imaging

2014
Incidence of chemotherapy-induced ovarian failure in premenopausal women undergoing chemotherapy for breast cancer.
    World journal of surgery, 2014, Volume: 38, Issue:9

    Topics: Adult; Age Factors; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Asia; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Estradiol; Female; Fluorouracil; Follicle Stimulating Hormone; Humans; Incidence; Induction Chemotherapy; Menstruation; Middle Aged; Premenopause; Primary Ovarian Insufficiency; Prospective Studies; Retrospective Studies; Tamoxifen; Taxoids; Young Adult

2014
Prognostic, predictive abilities and concordance of BCL2 and TP53 protein expression in primary breast cancers and axillary lymph-nodes: a retrospective analysis of the Belgian three arm study evaluating anthracycline vs CMF adjuvant chemotherapy.
    Breast (Edinburgh, Scotland), 2014, Volume: 23, Issue:4

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Humans; Lymph Nodes; Methotrexate; Middle Aged; Prognosis; Proto-Oncogene Proteins c-bcl-2; Retrospective Studies; Treatment Outcome; Tumor Suppressor Protein p53

2014
Correlation of tumor-infiltrative lymphocyte subtypes alteration with neoangiogenesis before and after neoadjuvant chemotherapy treatment in breast cancer patients.
    The International journal of biological markers, 2014, Sep-30, Volume: 29, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Forkhead Transcription Factors; Humans; Immunohistochemistry; Immunophenotyping; Lymphocyte Subsets; Lymphocytes, Tumor-Infiltrating; Neoadjuvant Therapy; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Stromal Cells; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Taxoids; Tumor Microenvironment

2014
The actual scenario of neoadjuvant chemotherapy of breast cancer in developing country: a report of 80 cases of breast cancer from a tertiary cancer center in India.
    Journal of cancer research and clinical oncology, 2014, Volume: 140, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; India; Induction Chemotherapy; Lymphatic Metastasis; Medical Records; Middle Aged; Molecular Targeted Therapy; Neoadjuvant Therapy; Neoplasm Staging; Postmenopause; Premenopause; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Rural Population; Tertiary Care Centers; Treatment Outcome

2014
PIK3CA mutations are a predictor of docetaxel plus epirubicin neoadjuvant chemotherapy clinical efficacy in breast cancer.
    Neoplasma, 2014, Volume: 61, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Class I Phosphatidylinositol 3-Kinases; Docetaxel; Epirubicin; ErbB Receptors; Female; Follow-Up Studies; Humans; Middle Aged; Mutation; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Phosphatidylinositol 3-Kinases; Prognosis; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); PTEN Phosphohydrolase; ras Proteins; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Taxoids

2014
Outcomes of immediate perforator flap reconstruction after skin-sparing mastectomy following neoadjuvant chemotherapy.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2015, Volume: 41, Issue:1

    Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Docetaxel; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Mammaplasty; Mastectomy, Subcutaneous; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Perforator Flap; Retrospective Studies; Taxoids; Trastuzumab; Treatment Outcome; Young Adult

2015
Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases.
    British journal of cancer, 2015, Jan-20, Volume: 112, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Carcinoma, Ductal, Breast; Cell Line, Tumor; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Gene Expression; Gene Knockdown Techniques; Hepatocyte Nuclear Factor 3-alpha; Humans; Kaplan-Meier Estimate; Ki-67 Antigen; Middle Aged; Neoadjuvant Therapy; Proportional Hazards Models; Receptor, ErbB-2; Receptors, Progesterone; Retrospective Studies; Taxoids; Treatment Outcome; Young Adult

2015
BRCA2-associated therapy-related acute myeloid leukemia.
    Medical oncology (Northwood, London, England), 2015, Volume: 32, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Genes, BRCA2; Humans; Leukemia, Myeloid, Acute; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Taxoids

2015
The nuclear expression of poly (ADP-ribose) polymerase-1 (PARP1) in invasive primary breast tumors is associated with chemotherapy sensitivity.
    Pathology, research and practice, 2015, Volume: 211, Issue:2

    Topics: Adult; Aged; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Female; Follow-Up Studies; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Logistic Models; Middle Aged; Neoadjuvant Therapy; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Retrospective Studies; Taxoids; Treatment Outcome

2015
Prognostic factors in operable breast cancer treated with neoadjuvant chemotherapy: towards a quantification of residual disease.
    Oncology, 2015, Volume: 88, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Confounding Factors, Epidemiologic; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Follow-Up Studies; France; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neoplasm, Residual; Prognosis; Retrospective Studies; Risk Factors; Taxoids; Treatment Outcome

2015
Effect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapy.
    British journal of cancer, 2015, Feb-17, Volume: 112, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Protein Kinase Inhibitors; Receptor, ErbB-2; Retrospective Studies; Trastuzumab

2015
Prediction of pathological complete response to neoadjuvant chemotherapy by magnetic resonance imaging in breast cancer patients.
    Breast (Edinburgh, Scotland), 2015, Volume: 24, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cohort Studies; Cyclophosphamide; Decision Support Techniques; Epirubicin; Estrogen Receptor alpha; Female; Fluorouracil; Humans; Magnetic Resonance Imaging; Mastectomy; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Paclitaxel; Prognosis; Receptor, ErbB-2; Receptors, Progesterone; Retrospective Studies; Treatment Outcome; Tumor Burden; Young Adult

2015
Integrated Analysis of PTEN and p4EBP1 Protein Expression as Predictors for pCR in HER2-Positive Breast Cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, 06-01, Volume: 22, Issue:11

    Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Cell Cycle Proteins; Class I Phosphatidylinositol 3-Kinases; Cyclophosphamide; DNA Mutational Analysis; Docetaxel; Epirubicin; Gene Expression; Humans; Middle Aged; Mutation; Phosphoproteins; PTEN Phosphohydrolase; Receptor, ErbB-2; Taxoids; Trastuzumab; Treatment Outcome; Young Adult

2016
[A Case of Locally-Advanced Breast Cancer with Liver Metastasis, Treated with Mastectomy of the Primary Tumor after Chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Estrogen Replacement Therapy; Female; Humans; Liver Neoplasms; Mastectomy; Neoplasm Staging; Tamoxifen

2015
Role of the Intravoxel Incoherent Motion Diffusion Weighted Imaging in the Pre-treatment Prediction and Early Response Monitoring to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.
    Medicine, 2016, Volume: 95, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Diffusion Magnetic Resonance Imaging; Epirubicin; Female; Humans; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Predictive Value of Tests

2016
Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study.
    BMC cancer, 2016, 05-19, Volume: 16

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Epirubicin; Female; Humans; Kaplan-Meier Estimate; Lymphocyte Count; Lymphocytes; Multivariate Analysis; Neoadjuvant Therapy; Neutrophils; Prognosis; Proportional Hazards Models; Retrospective Studies; ROC Curve; Taxoids; Trastuzumab; Treatment Outcome

2016
Evaluation of the tracing effect of carbon nanoparticle and carbon nanoparticle-epirubicin suspension in axillary lymph node dissection for breast cancer treatment.
    World journal of surgical oncology, 2016, Jun-22, Volume: 14, Issue:1

    Topics: Adenocarcinoma, Mucinous; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Medullary; Case-Control Studies; Charcoal; Combined Modality Therapy; Epirubicin; Female; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Nanoparticles; Neoplasm Invasiveness; Neoplasm Staging; Prognosis

2016
Rates of major complications during neoadjuvant and adjuvant chemotherapy for early breast cancer: An off study population.
    Breast (Edinburgh, Scotland), 2016, Volume: 30

    Topics: Acute Coronary Syndrome; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy-Induced Febrile Neutropenia; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Humans; Incidence; Mastectomy; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Pulmonary Embolism; Retrospective Studies; Risk Factors; Sentinel Lymph Node Biopsy; Stroke; Taxoids; Thromboembolism; Venous Thrombosis

2016
Combination of shear wave elastography and Ki-67 index as a novel predictive modality for the pathological response to neoadjuvant chemotherapy in patients with invasive breast cancer.
    European journal of cancer (Oxford, England : 1990), 2016, Volume: 69

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Docetaxel; Elasticity Imaging Techniques; Epirubicin; Female; Fluorouracil; Humans; Ki-67 Antigen; Mastectomy; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neoplasm, Residual; Prospective Studies; Taxoids; Trastuzumab; Treatment Outcome; Tumor Burden; Ultrasonography, Mammary

2016
Epirubicin/vinorelbine adjuvant chemotherapy in young women with breast cancer is associated with preservation of menstrual function.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2008, Volume: 20, Issue:7

    Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Disease-Free Survival; Epirubicin; Female; Fertility; Humans; Medical Records; Middle Aged; Retrospective Studies; Vinblastine; Vinorelbine

2008
Coincidential successful treatment of Jessner-Kanof disease with chemotherapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:7

    Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphocytes; Mastectomy, Radical; Recurrence; Skin Diseases; Time Factors; Treatment Outcome

2008
[Acute abdomen in a chemotherapy treated breast cancer patient].
    Cirugia espanola, 2009, Volume: 85, Issue:2

    Topics: Abdomen, Acute; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Docetaxel; Epirubicin; Female; Humans; Middle Aged; Taxoids

2009
Images in clinical medicine. Extravasation of epirubicin.
    The New England journal of medicine, 2009, May-14, Volume: 360, Issue:20

    Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Epirubicin; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Infusions, Intravenous; Middle Aged

2009
[Efficacy of neoadjuvant chemotherapy with FEC and TEC regimen on breast cancer].
    Ai zheng = Aizheng = Chinese journal of cancer, 2009, Volume: 28, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Remission Induction; Survival Rate

2009
A remarkable case of cutaneous metastatic breast carcinoma.
    Dermatology online journal, 2009, Jul-15, Volume: 15, Issue:7

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Combined Modality Therapy; Docetaxel; Epirubicin; Female; Humans; Mammaplasty; Mastectomy, Modified Radical; Middle Aged; Neoadjuvant Therapy; Nitriles; Radiography; Skin Neoplasms; Taxoids; Triazoles

2009
[A case of giant breast cancer performed a radical excision after neoadjuvant chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:12

    Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Neoadjuvant Therapy

2009
[A case of premenopausal stage IV breast cancer responding to neoadjuvant endocrine therapy after chemotherapy with FEC].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:1

    Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Goserelin; Humans; Mastectomy; Neoadjuvant Therapy; Premenopause; Tamoxifen

2010
[Effect of neoadjuvant chemotherapy on histologic grade and expression of biological markers in breast cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2009, Volume: 31, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Docetaxel; Epirubicin; Female; Humans; Ki-67 Antigen; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Taxoids

2009
Successful neoadjuvant therapy with trastuzumab, paclitaxel and epirubicin for an elderly patient with inflammatory breast cancer.
    Anticancer research, 2010, Volume: 30, Issue:2

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Epirubicin; Female; Humans; Neoadjuvant Therapy; Paclitaxel; Remission Induction; Trastuzumab; Treatment Outcome

2010
GSTT1, GSTM1, and GSTP1 polymorphisms and chemotherapy response in locally advanced breast cancer.
    Genetics and molecular research : GMR, 2010, Jun-11, Volume: 9, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Brazil; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Glutathione; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Middle Aged; Polymorphism, Genetic; Treatment Outcome

2010
Semi-quantitative evaluation of estrogen receptor expression is a strong predictive factor of pathological complete response after anthracycline-based neo-adjuvant chemotherapy in hormonal-sensitive breast cancer.
    Breast cancer research and treatment, 2010, Volume: 124, Issue:2

    Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy, Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Chi-Square Distribution; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Immunohistochemistry; Ki-67 Antigen; Logistic Models; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Hormone-Dependent; Patient Selection; Predictive Value of Tests; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Risk Assessment; Risk Factors; Treatment Outcome

2010
Specific congenital malformations after exposure to cyclophosphamide, epirubicin and 5-fluorouracil during the first trimester of pregnancy.
    Gynecologic and obstetric investigation, 2011, Volume: 71, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ductal, Breast; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Limb Deformities, Congenital; Male; Micrognathism; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, First

2011
[A case of multicentric breast cancer in which an effect of neoadjuvant chemotherapy had a disparity].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasms, Multiple Primary

2010
Exclusive alternating chemotherapy and radiotherapy in nonmetastatic inflammatory breast cancer: 20 years of follow-up.
    International journal of radiation oncology, biology, physics, 2012, Feb-01, Volume: 82, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachial Plexus Neuropathies; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Combined Modality Therapy; Cyclophosphamide; Dose Fractionation, Radiation; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fibrosis; Fluorouracil; Follow-Up Studies; Heart; Humans; Inflammatory Breast Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Radiation Injuries; Radiation Pneumonitis; Survival Rate; Tamoxifen; Time Factors; Vincristine

2012
Case of epirubicin-induced cardiomyopathy in familial cardiomyopathy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jun-20, Volume: 29, Issue:18

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Ductal, Breast; Cardiac Myosins; Cardiomegaly; Cardiomyopathy, Dilated; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Death, Sudden, Cardiac; Dothiepin; Dyspnea; Epirubicin; Female; Fluorouracil; Heart Failure; Humans; Male; Mastectomy, Segmental; Middle Aged; Migraine Disorders; Mutation, Missense; Myosin Heavy Chains; Point Mutation; Radiotherapy, Adjuvant

2011
Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer--results from the GeparQuattro study (GBG 40).
    Breast cancer research and treatment, 2012, Volume: 132, Issue:3

    Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Clinical Trials, Phase III as Topic; Cyclophosphamide; Deoxycytidine; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Receptor, ErbB-2; Taxoids; Trastuzumab; Treatment Outcome

2012
Circulating tumor cells count and characterization in a male breast cancer patient.
    Cancer biology & therapy, 2011, Sep-01, Volume: 12, Issue:5

    Topics: Breast Neoplasms, Male; Carboplatin; Carcinoma, Ductal, Breast; Cell Count; Deoxycytidine; Docetaxel; Drug Resistance, Neoplasm; Epirubicin; Gemcitabine; Humans; Male; Middle Aged; Neoplastic Cells, Circulating; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Taxoids

2011
Tumor topoisomerase II alpha status and response to anthracycline-based neoadjuvant chemotherapy in breast cancer.
    Oncology, 2011, Volume: 80, Issue:3-4

    Topics: Adult; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Deoxycytidine; Disease-Free Survival; DNA Topoisomerases, Type II; DNA-Binding Proteins; Docetaxel; Epirubicin; Female; Fluorouracil; Gene Expression; Genes, erbB-2; Humans; Immunochemistry; In Situ Hybridization, Fluorescence; Ki-67 Antigen; Middle Aged; Neoadjuvant Therapy; Poly-ADP-Ribose Binding Proteins; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Survival Analysis; Taxoids; Treatment Outcome

2011
Ubc9 expression predicts chemoresistance in breast cancer.
    Chinese journal of cancer, 2011, Volume: 30, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Disease Progression; Disease-Free Survival; Drug Resistance, Neoplasm; Epirubicin; Female; Fluorouracil; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Lymphatic Metastasis; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Proportional Hazards Models; Remission Induction; Tumor Burden; Ubiquitin-Conjugating Enzymes; Up-Regulation

2011
[Primary systemic therapy in breast cancer patients (2007-2010)].
    Magyar sebeszet, 2011, Volume: 64, Issue:5

    Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Carcinoma; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Carcinoma, Medullary; Carcinoma, Papillary; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Neoplasm, Residual; Radiography; Retrospective Studies; Taxoids; Treatment Outcome

2011
A prognostic model to predict outcome of patients failing to achieve pathological complete response after anthracycline-containing neoadjuvant chemotherapy for breast cancer.
    Journal of surgical oncology, 2012, Volume: 105, Issue:6

    Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Cathepsin D; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Ki-67 Antigen; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Prognosis; Vinblastine; Vinorelbine; Young Adult

2012
[Predictive value of (99)Tc(m)-MIBI scintimammography in evaluation of the efficacy of neoadjuvant chemotherapy in patients with operable breast cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2011, Volume: 33, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Taxoids; Technetium Tc 99m Sestamibi

2011
3D breast ultrasound: a significant predictor in breast cancer reduction under pre-operative chemotherapy.
    Anticancer research, 2011, Volume: 31, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Chemotherapy, Adjuvant; Epirubicin; Female; Humans; Imaging, Three-Dimensional; Middle Aged; Neoplasm Staging; Paclitaxel; Preoperative Care; Prognosis; Remission Induction; Ultrasonography, Mammary

2011
Identification of potential markers related to neoadjuvant chemotherapy sensitivity of breast cancer by SELDI-TOF MS.
    Applied biochemistry and biotechnology, 2012, Volume: 166, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Pharmacological; Biomarkers, Tumor; Biopsy, Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Complement C3a; Cyclophosphamide; Cytarabine; Drug Resistance, Neoplasm; Epirubicin; Female; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Proteomics; Reproducibility of Results; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2012
[Invasive ductal carcinoma and chronic lymphocytic leukemia: a unique case of collision tumor in breast].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 2011, Volume: 40, Issue:10

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Epirubicin; Female; Follow-Up Studies; Humans; Immunohistochemistry; Leukemia, Lymphocytic, Chronic, B-Cell; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasms, Multiple Primary; Paclitaxel

2011
[Correlation of expression of Survivin, BCRP and HER-2 genes with therapeutic response of TE regimen neoadjuvant chemotherapy in breast cancer patients].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2011, Volume: 33, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Disease Progression; Docetaxel; Epirubicin; Female; Humans; Inhibitor of Apoptosis Proteins; Mastectomy, Radical; Middle Aged; Neoadjuvant Therapy; Neoplasm Proteins; Receptor, ErbB-2; Remission Induction; RNA, Messenger; Survivin; Taxoids

2011
Prognostic value of a positive-to-negative change in hormone receptor status after neoadjuvant chemotherapy in patients with hormone receptor-positive breast cancer.
    Annals of surgical oncology, 2012, Volume: 19, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Ki-67 Antigen; Mastectomy; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Predictive Value of Tests; Proportional Hazards Models; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Taxoids; Vinblastine; Vinorelbine

2012
Mandibular metastases as first clinical sign of an occult male breast cancer.
    International journal of oral and maxillofacial surgery, 2012, Volume: 41, Issue:10

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Cyclophosphamide; Epirubicin; Fluorouracil; Humans; Magnetic Resonance Imaging; Male; Mandibular Condyle; Mandibular Neoplasms; Radiography

2012
Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy.
    Breast cancer research and treatment, 2012, Volume: 134, Issue:2

    Topics: Acid Phosphatase; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone and Bones; Breast Neoplasms; Calcium; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Collagen; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Intercellular Signaling Peptides and Proteins; Isoenzymes; Middle Aged; Neoadjuvant Therapy; Osteoprotegerin; Peptide Fragments; Prevalence; RANK Ligand; Retrospective Studies; Statistics, Nonparametric; Tartrate-Resistant Acid Phosphatase; Taxoids; TNF-Related Apoptosis-Inducing Ligand; Vitamin D; Vitamin D Deficiency

2012
Prognostic molecular markers and neoadjuvant therapy response in anthracycline-treated breast cancer patients.
    Archives of gynecology and obstetrics, 2013, Volume: 287, Issue:2

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Follow-Up Studies; Humans; Immunohistochemistry; Logistic Models; Mastectomy; Middle Aged; Neoadjuvant Therapy; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome

2013
Potential application value of contrast-enhanced ultrasound in neoadjuvant chemotherapy of breast cancer.
    Ultrasound in medicine & biology, 2012, Volume: 38, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Contrast Media; Docetaxel; Epirubicin; Female; Humans; Middle Aged; Neoadjuvant Therapy; Taxoids; Ultrasonography, Doppler, Color; Ultrasonography, Mammary

2012
Plasma and tissue proteomic prognostic factors of response in primary breast cancer patients receiving neoadjuvant chemotherapy.
    Oncology reports, 2013, Volume: 29, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blood Proteins; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Prognosis; Protein Array Analysis; Proteomics; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Survival Rate; Taxoids

2013
Plasma DNA integrity indicates response to neoadjuvant chemotherapy in patients with locally confined breast cancer.
    International journal of clinical pharmacology and therapeutics, 2013, Volume: 51, Issue:1

    Topics: Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; DNA; Docetaxel; Epirubicin; Female; Follow-Up Studies; Humans; Neoadjuvant Therapy; Taxoids; Treatment Outcome

2013
Study of chromosome damage in patients with breast cancer treated by two antineoplastic treatments.
    Teratogenesis, carcinogenesis, and mutagenesis, 2002, Volume: 22, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cell Division; Chromosome Aberrations; Chromosomes, Human; Cyclophosphamide; DNA Damage; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Mitotic Index; Sister Chromatid Exchange

2002
Coordinate expression of apoptosis-associated proteins in human breast cancer before and during chemotherapy.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Caspase 3; Caspase 6; Caspases; Cisplatin; Cyclophosphamide; Deoxyribonucleases; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Middle Aged; Neoplasm Proteins; Poly-ADP-Ribose Binding Proteins; Proteins; Proto-Oncogene Proteins c-bcl-2; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; X-Linked Inhibitor of Apoptosis Protein

2002
High incidence of central nervous system involvement in patients with breast cancer treated with epirubicin and docetaxel.
    American journal of clinical oncology, 2002, Volume: 25, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Central Nervous System Neoplasms; Combined Modality Therapy; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Paclitaxel; Taxoids

2002
Breast cancer: monitoring response to neoadjuvant chemotherapy using Tc-99m sestamibi scintimammography.
    Onkologie, 2003, Volume: 26, Issue:1

    Topics: Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Epirubicin; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Mammography; Neoadjuvant Therapy; Paclitaxel; Predictive Value of Tests; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Treatment Outcome

2003
[Acute tongue necrosis provoked by epirubicin-cyclophosphamide treatment for invasive ductal breast cancer].
    Mund-, Kiefer- und Gesichtschirurgie : MKG, 2003, Volume: 7, Issue:3

    Topics: Acute Disease; Airway Obstruction; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Humans; Middle Aged; Necrosis; Tongue; Tongue Diseases

2003
Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIalpha for anthracycline chemotherapy in locally advanced breast cancer.
    Breast cancer research and treatment, 2005, Volume: 92, Issue:1

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antigens, Neoplasm; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cell Proliferation; DNA Topoisomerases, Type II; DNA-Binding Proteins; Doxorubicin; Epirubicin; Female; Genes, erbB-2; Humans; Middle Aged; Neoplasm Staging; Pilot Projects; Predictive Value of Tests

2005
Chemotherapy for breast cancer during pregnancy.
    European journal of obstetrics, gynecology, and reproductive biology, 2005, Dec-01, Volume: 123, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Mastectomy, Segmental; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prenatal Exposure Delayed Effects

2005
Epirubicin for breast cancer may cause considerable venous sclerosis.
    BMJ (Clinical research ed.), 2005, Oct-08, Volume: 331, Issue:7520

    Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Ductal, Breast; Epirubicin; Female; Humans; Middle Aged; Sclerosis; Venous Thrombosis

2005
Overexpression of caspase-3s splice variant in locally advanced breast carcinoma is associated with poor response to neoadjuvant chemotherapy.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Oct-01, Volume: 12, Issue:19

    Topics: Alternative Splicing; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Carcinoma, Ductal, Breast; Caspase 3; Caspase Inhibitors; Caspases; Chemotherapy, Adjuvant; Cyclophosphamide; Disease Progression; Drug Resistance, Neoplasm; Enzyme Precursors; Epirubicin; Female; Fluorouracil; Gene Expression Regulation; Humans; Middle Aged; Neoadjuvant Therapy; Tumor Cells, Cultured

2006
[Breast carcinoma and bone chondrosarcoma: a new syndrome?].
    Journal de radiologie, 2006, Volume: 87, Issue:11 Pt 1

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Chondrosarcoma; Combined Modality Therapy; Cyclophosphamide; Diagnosis, Differential; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Mammography; Middle Aged; Phenotype; Radiography, Thoracic; Radiotherapy Dosage; Ribs; Syndrome; Taxoids; Tomography, X-Ray Computed

2006
Multiple cutaneous metastases from male breast carcinoma.
    Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Epirubicin; Fatal Outcome; Fluorouracil; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mastectomy, Radical; Megestrol Acetate; Middle Aged; Paclitaxel; Palliative Care; Skin Neoplasms

2006
[Efficacy and toxicity of combination treatment with epirubicin (EPI) plus docetaxel (DOC) in advanced breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:11

    Topics: Adult; Alopecia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Humans; Middle Aged; Nausea; Neoadjuvant Therapy; Neoplasm Staging; Preoperative Care; Taxoids

2006
Infiltrating ductal carcinoma and synchronous malignant phyllodes tumour. Diagnostic and therapeutic approaches.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2006, Volume: 8, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Mastectomy, Modified Radical; Mastectomy, Simple; Middle Aged; Neoplasms, Multiple Primary; Phyllodes Tumor; Radiotherapy, Adjuvant; Remission Induction

2006
[A patient with advanced breast cancer refractory to chemotherapy accompanied by carcinomatous pleurisy and multiple bone metastasis that responded to combination therapy with high-dose toremifene and docetaxel].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:1

    Topics: Aged; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Paclitaxel; Pleural Effusion, Malignant; Pleural Neoplasms; Quality of Life; Remission Induction; Taxoids; Toremifene

2007
[A case of inflammatory breast cancer achieving pathological complete response by primary systemic therapy with CEF (cyclophosphamide, epirubicin, 5-fluorouracil) followed by docetaxel].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Inflammation; Mammography; Middle Aged; Remission Induction; Taxoids; Tomography, X-Ray Computed; Ultrasonography, Mammary

2007
Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
    Cancer, 2007, Apr-01, Volume: 109, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Doxorubicin; Epirubicin; False Negative Reactions; Feasibility Studies; Female; Fluorouracil; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Preoperative Care; Sentinel Lymph Node Biopsy; Time Factors; Ultrasonography, Mammary

2007
[Assessment of neoadjuvant chemotherapy in breast cancer patients].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2006, Volume: 28, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Docetaxel; Epirubicin; ErbB Receptors; Female; Fluorouracil; Humans; Logistic Models; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Receptors, Estrogen; Receptors, Progesterone; Remission Induction; Taxoids; Vinblastine; Vinorelbine

2006
Concomitant intensive chemoradiotherapy induction in non-metastatic inflammatory breast cancer: long-term follow-up.
    British journal of cancer, 2007, Oct-08, Volume: 97, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Dose Fractionation, Radiation; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Menopause; Middle Aged; Remission Induction; Survival Rate; Time Factors; Treatment Outcome

2007
Histological features of breast cancer, highly sensitive to chemotherapy.
    Breast cancer (Tokyo, Japan), 2007, Volume: 14, Issue:4

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Epirubicin; Female; Humans; Middle Aged; Neoadjuvant Therapy; Paclitaxel

2007
Metastatic ductal eccrine adenocarcinoma masquerading as an invasive ductal carcinoma of the male breast.
    Journal of cutaneous pathology, 2007, Volume: 34, Issue:12

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Cyclophosphamide; Diphosphonates; Eccrine Glands; Epirubicin; Fluorouracil; Humans; Ibandronic Acid; Immunohistochemistry; Lung Neoplasms; Lymphatic Metastasis; Male; Radiotherapy; Sweat Gland Neoplasms; Tamoxifen; Tomography, X-Ray Computed

2007
DNA damage in peripheral blood lymphocytes in patients during combined chemotherapy for breast cancer.
    Mutation research, 2008, Apr-02, Volume: 640, Issue:1-2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Comet Assay; Cyclophosphamide; DNA Damage; Epirubicin; Female; Fluorouracil; Humans; Lymphocytes; Middle Aged

2008
Integrated gene expression profile predicts prognosis of breast cancer patients.
    Breast cancer research and treatment, 2009, Volume: 113, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Proteins; Oligonucleotide Array Sequence Analysis; Prognosis; Proportional Hazards Models; RNA, Messenger; RNA, Neoplasm; Young Adult

2009
Determining the morphological features of breast cancer and predicting the effects of neoadjuvant chemotherapy via diagnostic breast imaging.
    Breast cancer (Tokyo, Japan), 2008, Volume: 15, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Papillary; Chemotherapy, Adjuvant; Cyclophosphamide; Diagnostic Imaging; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Neoadjuvant Therapy; Prognosis; Retrospective Studies; Stereoisomerism; Treatment Outcome

2008
Pathological lymph node involvement at surgery is a significant predictive factor of recurrence in locally advanced breast cancer treated with concomitant epirubicin-docetaxel neoadjuvant chemotherapy: a cohort study.
    Breast cancer (Tokyo, Japan), 2009, Volume: 16, Issue:1

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cohort Studies; Disease-Free Survival; Docetaxel; Epirubicin; Female; Humans; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Retrospective Studies; Taxoids

2009
[A case of inflammatory breast cancer treated with preoperative intra-arterial infusion chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:16

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Mastectomy, Extended Radical; Preoperative Care

1994
[Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy].
    Geburtshilfe und Frauenheilkunde, 1994, Volume: 54, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cell Division; Cell Survival; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Premedication

1994
Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm.
    Cancer, 1994, Aug-15, Volume: 74, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cobalt Radioisotopes; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy, Modified Radical; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Survival Rate; Tamoxifen; Treatment Failure; Vindesine

1994
A case of advanced male breast cancer successfully treated by 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy combined with tamoxifen.
    Nihon geka hokan. Archiv fur japanische Chirurgie, 1995, Jan-01, Volume: 64, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Fluorouracil; Humans; Lymphatic Metastasis; Male; Tamoxifen; Thoracic Neoplasms

1995
[Response evaluation with mammography and ultrasound].
    Zentralblatt fur Gynakologie, 1996, Volume: 118, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Humans; Mammography; Neoplasm Staging; Treatment Outcome; Ultrasonography, Mammary

1996
Tc-99m sestamibi scintimammography in the evaluation of response of breast carcinoma to chemotherapy.
    Clinical nuclear medicine, 1997, Volume: 22, Issue:9

    Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Evaluation Studies as Topic; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy, Modified Radical; Neoplasm Staging; Premenopause; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Treatment Outcome

1997
Intractable Crohn's colitis and perianal disease responding to cyclophosphamide and epirubicin.
    Digestive diseases and sciences, 1997, Volume: 42, Issue:11

    Topics: Alkylating Agents; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Colitis; Crohn Disease; Cyclophosphamide; Epirubicin; Female; Humans; Immunosuppressive Agents; Mastectomy; Middle Aged; Rectal Diseases

1997
Isolated pleural effusion with hematopoietic cells of mixed lineage in a patient receiving granulocyte-colony-stimulating factor after high-dose chemotherapy.
    Diagnostic cytopathology, 1998, Volume: 18, Issue:3

    Topics: Adult; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Cytodiagnosis; Epirubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunohistochemistry; Macrophages; Monocytes; Neoplasm Staging; Pleural Effusion; Recombinant Proteins

1998
[A case of giant advanced breast cancer responding remarkably to chemo-endocrine therapy chiefly with doxifluridine].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:14

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Floxuridine; Fluorouracil; Humans; Pleural Effusion, Malignant; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen

1998
[Neoadjuvant chemotherapy FEC-HD in locally advanced breast cancer].
    Bulletin du cancer, 1999, Volume: 86, Issue:2

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Thrombocytopenia

1999
[A patient with hepatic metastasis of breast cancer successfully treated with combined chemoendocrine therapy using epirubicin, tegafur and tamoxifen].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Administration Schedule; Epirubicin; Female; Humans; Liver Neoplasms; Middle Aged; Remission Induction; Tamoxifen; Tegafur

1999
[A case of recurrent breast cancer successfully treated with docetaxel].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:10

    Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Middle Aged; Paclitaxel; Taxoids

1999
[Clinical study of selective intra-arterial infusion chemotherapy using trans-radial arterial approach in 4 cases of advanced breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:2

    Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Administration Schedule; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Middle Aged; Neoadjuvant Therapy; Radial Artery

2000
Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Epirubicin; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Paclitaxel; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed

2000
[A clinical report of high-dose epirubicin combined with cyclophosphamide and fluorouracil for advanced breast cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1998, Volume: 20, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Medullary; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging

1998
Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer.
    British journal of cancer, 2000, Volume: 83, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Staging; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate; Thiotepa; Treatment Outcome

2000
[MR mammography of response-control in primary chemo-brachytherapy in BCT-inoperable breast cancer].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2001, Volume: 173, Issue:1

    Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Brachytherapy; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Combined Modality Therapy; Contrast Media; Cyclophosphamide; Drug Therapy, Combination; Epirubicin; Female; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Middle Aged; Preoperative Care; Time Factors

2001
5-fluorouracil-induced leukoencephalopathy in patients with breast cancer.
    Journal of Korean medical science, 2001, Volume: 16, Issue:3

    Topics: Adenocarcinoma, Mucinous; Adult; Anti-Inflammatory Agents; Antineoplastic Agents; Brain; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Glucocorticoids; Humans; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Nervous System Diseases; Prednisolone; Radiography

2001
[Results of treatment based on endocrine therapy for bone metastasis from breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Epirubicin; Female; Gonadotropin-Releasing Hormone; Humans; Medroxyprogesterone; Middle Aged; Palliative Care; Progesterone Congeners; Quality of Life; Survival Rate

2001
Successful management of breast cancer with liver metastases with medroxyprogesterone acetate treatment.
    International journal of clinical oncology, 2001, Volume: 6, Issue:6

    Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Mastectomy, Radical; Medroxyprogesterone Acetate; Tomography, X-Ray Computed; Treatment Outcome

2001
Assessment of response by breast helical computed tomography to neoadjuvant chemotherapy in large inflammatory breast cancer.
    Clinical breast cancer, 2002, Volume: 2, Issue:4

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Docetaxel; Drug Monitoring; Epirubicin; Female; Fluorouracil; Humans; Mammography; Mastectomy; Middle Aged; Mitoxantrone; Neoadjuvant Therapy; Paclitaxel; Physical Examination; Taxoids; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vinorelbine

2002